The FDA's decision to cancel the March meeting raises questions about flu vaccine guidance for manufacturers this year ...
U.S. health officials are reevaluating a $590 million contract that was awarded to Moderna for the development of its bird ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results